Companies Dominating the Malaria Ag Rapid Testing Landscape
- Wyss Institute
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Alere, Inc.
- Nectar Lifesciences Ltd.
- Teco Diagnostics
- Xiamen Boson Biotech Co. Ltd.
- HWTAi BioTec
- Arkray Inc.
- CTK Biotech Inc.
- Biosynex SA
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of malaria ag rapid testing is assessed at USD 38.44 billion.
The malaria ag rapid testing market size was over USD 36.93 billion in 2024 and is projected to reach USD 67.93 billion by 2037, growing at around 4.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in adoption of latest technology, rise in government initiatives for the awareness regarding malaria, and extreme weather event to increase prevalence of malaria.
North America industry is predicted to account for largest revenue share of 30% by 2037, due to rising travelers returning to North America.
The major players in the market are Wyss Institute, Novartis AG, Alere, Inc., Nectar Lifesciences Ltd., and others.
